Reiko Kuni‐Kamochi

Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types

Yutaka Kanda, Tsuyoshi Yamada, Katsuhiro Mori et al. · Glycobiology · 2006 · 370 citations

Engineering Chinese hamster ovary cells to maximize effector function of produced antibodies using FUT8 siRNA

Katsuhiro Mori, Reiko Kuni‐Kamochi, Naoko Yamane‐Ohnuki et al. · Biotechnology and Bioengineering · 2004 · 173 citations

Establishment of a GDP-mannose 4,6-dehydratase (GMD) knockout host cell line: A new strategy for generating completely non-fucosylated recombinant therapeutics

Yutaka Kanda, Harue Imai-Nishiya, Reiko Kuni‐Kamochi et al. · Journal of Biotechnology · 2007 · 121 citations

Gdp-mannose 4,6-Dehydratase, Engineering, Biochemistry +10

Two mechanisms of the enhanced antibody-dependent cellular cytotoxicity (ADCC) efficacy of non-fucosylated therapeutic antibodies in human blood

Shigeru Iida, Reiko Kuni‐Kamochi, Katsuhiro Mori et al. · BMC Cancer · 2009 · 98 citations · Full text

Non-fucosylated therapeutic antibodies: the next generation of therapeutic antibodies

Katsuhiro Mori, Shigeru Iida, Naoko Yamane‐Ohnuki et al. · Cytotechnology · 2007 · 96 citations · Full text

Autoimmune Disease, Immunology, Antibody Screening +7